ArticleOncology letters2025

Single‑center, retrospective, evaluator‑blinded, pilot and pivotal clinical trials: Assessing the mirCaP Kit (hsv2‑miR‑H9/hsa‑miR‑3659) as a diagnostic marker for prostate cancer in patients with PSA levels in the gray zone.

Won Tae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.